A global leader in medical technology, the company develops and markets innovative solutions for surgical and regenerative medicine. Its products are widely used in neurosurgery, orthopedics, and wound care, making it a key player in the healthcare sector. Investors monitor its performance due to its strong market position and consistent revenue growth in a high-demand industry.
6 members of Congress have disclosed 16 trades in Integra LifeSciences Holdings Corporation (IART), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 10 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-06-18 | Josh Gottheimer | sell | $1K – $15K |
| 2024-04-05 | Josh Gottheimer | sell | $1K – $15K |
| 2023-10-16 | Josh Gottheimer | buy | $1K – $15K |
| 2023-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2023-06-13 | Josh Gottheimer | sell | $1K – $15K |
| 2020-10-16 | Josh Gottheimer | buy | $1K – $15K |
| 2020-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2020-03-10 | Gilbert Cisneros | buy | $1K – $15K |
| 2020-02-10 | Gilbert Cisneros | buy | $1K – $15K |
| 2020-02-03 | Josh Gottheimer | buy | $1K – $15K |
| 2019-01-09 | Donna Shalala | sell | $1K – $15K |
| 2018-08-20 | JAMES B. RENACCI | buy | $1K – $15K |
| 2018-02-27 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-07-18 | JAMES B. RENACCI | sell | $50K – $100K |
| 2015-08-20 | JAMES B. RENACCI | sell | $1K – $15K |
| 2015-02-13 | Thomas R Tillis | sell | $1K – $15K |